The factor XIII Val34Leu polymorphism: Is it protective against idiopathic venous thromboembolism?

Philip S. Wells, Josdalyne L. Anderson, Marc A. Rodger, Nancy Carson, Rebecca L. Grimwood, Steve P. Doucette

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


The substitution of leucine for valine at amino acid position 34 of the factor XIII gene is commonly referred to as FXIII Val34Leu polymorphism. The homozygous leucine/leucine genotype has been reported to confer protection against venous thromboembolism, but previous studies have not evaluated a population limited to those with idiopathic venous thromboembolism. The primary objective of the study was to determine whether the FXIII Val34Leu polymorphism is independently associated with the occurrence of idiopathic venous thromboembolism. We prospectively enrolled consecutive patients with at least one objectively confirmed idiopathic venous thromboembolism. Friends of cases were recruited as controls and matched to cases by sex, ethnicity, and age. All participants were tested for the FXIII Val34Leu polymorphism in addition to several well-known thrombophilias. Data from 309 cases and 306 controls were analyzed. The FXIII leucine/leucine genotype was present in 4.9% of cases and 6.5% of controls. An adjusted odds ratio of 0.59 (95% confidence interval, 0.25-1.38) was found for the recessive model and 0.69 (95% confidence interval, 0.46-1.02) for the dominant model. Our results do not support an independent association of the FXIII Val34Leu polymorphism with idiopathic venous thromboembolism in our Caucasian Canadian study population.

Original languageEnglish
Pages (from-to)533-538
Number of pages6
JournalBlood Coagulation and Fibrinolysis
Issue number7
StatePublished - Oct 2006
Externally publishedYes


  • Clinical studies
  • Deep vein thrombosis
  • Epidemiological studies
  • Factor XIII
  • Pulmonary embolism
  • Thrombophilia
  • Transglutaminases


Dive into the research topics of 'The factor XIII Val34Leu polymorphism: Is it protective against idiopathic venous thromboembolism?'. Together they form a unique fingerprint.

Cite this